Suche Bilder Maps Play YouTube News Gmail Drive Mehr »
Einstellungen | Anmelden

Neuroscience Area Manager Providence RI

URI names inaugural dean of new College of Health Sciences

The Providence Journal - ‎25.07.2016‎
SOUTH KINGSTOWN, R.I. - The University of Rhode Island has named a University of Tennessee Chattanooga educator and researcher to be the first dean of the College of Health Sciences, the first new college established at URI in some four decades ...

URI professor leading ground-breaking research into Alzheimer's disease

The Providence Journal - ‎24.07.2016‎
Her groundbreaking studies of the role the vascular system plays in Alzheimer's so impressed the University of Rhode Island that it recruited her to be the inaugural director of the new George and Anne Ryan Institute for Neuroscience, established with ...

Vandals deface Kingston mosque

The Providence Journal - ‎15.07.2016‎
I think this is an isolated incident and doesn't in any way reflect our Rhode Island community." Zawia is dean of the Graduate School at URI and a professor of pharmacology, toxicology and neuroscience. He was a founding member of the Islamic center, ...

Slater Fund offers $500000 for new drug-discovery firm

The Providence Journal - ‎14.07.2016‎
PROVIDENCE, R.I. -- The Slater Technology Fund on Thursday announced it is dedicating $500,000 in seed funding to help launch MindImmune Therapeutics, a company that hopes to develop drugs that will utilize the immune system to treat such neurological ...

Family Diagnostic Medical Center Joins Providence Network

Hillsboro Reporter - ‎14.07.2016‎
It was announced last week that Family Diagnostic Medical Center (FDMC) in Hillsboro had joined Providence Healthcare Network as part of the Providence Health Alliance. ... In addition to healthcare delivery, Ascension subsidiaries provide a variety of ...

Slater Commits Seed Funding to MindImmune Therapeutics, Drug Discovery ...

URI Today (press release) - ‎14.07.2016‎
Providence, R.I., July 14, 2016 - The Slater Technology Fund today announced that it has committed $500,000 in seed funding to support the launch of MindImmune Therapeutics, Inc., a Rhode Island-based drug discovery venture that aims to establish a ...
 -